• Bafilomycin A1: Precision V-ATPase Inhibitor for Lysosomal S

  2026-04-19

  Bafilomycin A1 empowers researchers to dissect lysosomal function, intracellular pH regulation, and proteostasis with nanomolar precision. This guide delivers actionable workflows, advanced troubleshooting, and contextualizes new insights from centriolar satellite research to optimize your use of this gold-standard V-ATPase inhibitor.

• Trichostatin A: HDAC Inhibitor Optimizing Epigenetic Workflo

  2026-04-18

  Trichostatin A (TSA) from APExBIO is a benchmark HDAC inhibitor, empowering researchers to induce robust histone acetylation, cell cycle arrest, and antiproliferative effects in cancer models. This guide details stepwise protocols, advanced applications, and troubleshooting strategies to maximize TSA’s impact in epigenetic and oncology research.

• Bradykinin B2 Receptor Modulation of Ileal Peristalsis: Key

  2026-04-17

  This study demonstrates that bradykinin inhibits peristaltic reflexes in the guinea pig ileum via B2 receptor activation, a novel mechanistic insight for gastrointestinal motility research. The findings clarify receptor subtype roles and provide a pharmacological basis for future studies targeting bradykinin pathways in gut physiology.

• LGK-974: Benchmark PORCN Inhibitor for Wnt Pathway Research

  2026-04-16

  LGK-974 empowers researchers with nanomolar-precision inhibition of the Wnt signaling pathway, enabling robust modeling of Wnt-driven cancer and β-catenin transcriptional activity. Explore how this potent PORCN inhibitor, supplied by APExBIO, streamlines experimental workflows and delivers reproducible results in both in vitro and in vivo systems.

• AI-Derived Prognostic Signature Enhances HCC Risk Stratifica

  2026-04-15

  This large-scale, multi-center study introduces a consensus artificial intelligence-driven prognostic signature (CAIPS) for hepatocellular carcinoma (HCC), surpassing existing clinical and molecular models in risk prediction. CAIPS integrates machine learning with multi-omics analysis, revealing actionable biomarkers and candidate therapeutics, advancing precision oncology for HCC.

• DiscoveryProbe Protease Inhibitor Library: Enabling Mechanis

  2026-04-14

  Explore how the DiscoveryProbe Protease Inhibitor Library empowers next-generation oncology and apoptosis assays through mechanistic insight into protease inhibition. Uncover unique strategies for target validation and high content screening that set this resource apart.

• A-769662: Redefining AMPK Activation in Energy Stress Resear

  2026-04-13

  Explore the unique, dual-action profile of A-769662 as an AMPK activator and proteasome modulator. This article offers an advanced analysis, integrating new mechanistic insights for researchers investigating energy metabolism regulation and metabolic disease.

• Strategic Caspase Inhibition: Advancing Inflammation & Cance

  2026-04-13

  This article explores the mechanistic and translational value of Z-WEHD-FMK, a potent irreversible caspase inhibitor, for dissecting pyroptosis, apoptosis, and inflammatory signaling in disease models. Anchored by recent primary research on HOXC8 and caspase-1 in lung tumorigenesis, we examine experimental best practices, competitive differentiation, and future directions for researchers leveraging Z-WEHD-FMK in cell biology and infectious disease research.

• Doxorubicin in Translational Oncology: Mechanism to Impact

  2026-04-12

  This thought-leadership article explores how Doxorubicin (Adriamycin), a cornerstone chemotherapeutic agent, is reshaping translational cancer research. We dissect its mechanistic underpinnings, highlight state-of-the-art validation using high-content phenotypic screening, and provide strategic guidance for researchers navigating efficacy, resistance, and toxicity. Drawing on recent evidence and APExBIO’s Doxorubicin (A3966) as a benchmark tool, the discussion bridges molecular insight with actionable protocol guidance and future-facing perspectives.

• Cy5 maleimide (non-sulfonated): Protocols for Thiol Labeling

  2026-04-12

  Cy5 maleimide (non-sulfonated) addresses the need for site-specific, covalent fluorescent labeling of proteins and peptides through cysteine residues. It is optimized for workflows requiring high-purity thiol-reactive dyes and precise probe conjugation but is not recommended where water solubility or non-thiol selectivity is required.

• Cisapride (R 51619): Best Practices in Cardiac Electrophysio

  2026-04-11

  Cisapride (R 51619) empowers researchers to dissect cardiac electrophysiology and cardiotoxicity with precision, especially in high-content phenotypic screening using iPSC-derived cardiomyocytes. This article delivers actionable protocols, troubleshooting insights, and comparative analysis to maximize data quality and translational relevance for cardiac arrhythmia research.

• Gamithromycin: Advanced Protocols for Veterinary Respiratory

  2026-04-11

  Gamithromycin, a potent 15-membered semi-synthetic macrolide antibiotic, is redefining experimental workflows for respiratory disease models in animals. This guide translates recent PK/PD breakthroughs and comparative data into actionable protocols, troubleshooting strategies, and assay optimization for Pasteurella multocida and related pathogens.

• Proteinase K (K1037): Recombinant Broad-Spectrum Serine P...

  2026-04-10

  Proteinase K is a broad-spectrum serine protease produced recombinantly in Pichia pastoris, widely recognized for robust protein hydrolysis and contaminant removal in molecular biology workflows. Its high stability, resistance to common inhibitors, and proven effectiveness in preserving DNA integrity make it an essential reagent for genomic DNA isolation and protein digestion applications.

• Actinomycin D: Precision Transcriptional Inhibitor in Can...

  2026-04-09

  Actinomycin D (ActD) is the gold-standard transcriptional inhibitor powering high-fidelity mRNA stability, apoptosis, and DNA damage response assays. Its robust performance, unique mechanistic precision, and versatile workflow compatibility make it the top choice for dissecting RNA polymerase inhibition and transcriptional stress in advanced cancer research.

• DiscoveryProbe Protease Inhibitor Library: High-Throughpu...

  2026-04-08

  The DiscoveryProbe Protease Inhibitor Library offers validated, cell-permeable compounds for high-throughput screening of protease activity in apoptosis, cancer, and infectious disease research. This protease inhibitor library enables reproducible mechanistic assays and sets a new benchmark for high content screening applications.

16009 records 3/1068 page Previous Next 12345 下5页 Last page